CION Ameerpet
An endometrioma is a benign cyst caused by endometriosis involving the ovary. It is not cancer and the overwhelming majority never become cancer — but the link is real enough to be worth understanding properly rather than half-reading.
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it. When it involves an ovary, it can form a cyst that fills with blood. That blood is not cleared away, so it sits and darkens over months and years into a thick brown fluid — which is where the informal name chocolate cyst comes from.
On ultrasound an endometrioma has a distinctive appearance: uniform, fine, low-level internal echoes throughout, usually described as a ground-glass pattern, with no solid areas and no internal blood flow. It will always be reported as a complex cyst, because it is not clear fluid — but that particular complex pattern is recognisable and reassuring rather than alarming.
Endometriomas are benign. They are also almost always a sign of endometriosis elsewhere in the pelvis, which matters because that condition frequently goes undiagnosed for years. Many women arrive having been told since their teens that severe period pain is normal. The endometrioma is often the thing that finally gets the underlying condition named.
The cyst fills with blood that cannot escape, which darkens over time. That is the whole mechanism, and it is benign.
Uniform ground-glass echoes, no solid areas, no internal blood flow. Complex on paper, and a known benign pattern in practice.
An endometrioma almost always means endometriosis elsewhere too — worth diagnosing and treating in its own right.
Endometriosis routinely raises CA-125, and endometriomas raise it more than most other benign causes. This matters enormously in practice: a woman with a known endometrioma who has a CA-125 measured will very often get a raised result, and if that number is read without the context it triggers weeks of avoidable fear and sometimes unnecessary tests. A raised CA-125 alongside a classic ground-glass cyst in a premenopausal woman is an expected finding, not a warning sign. The scan appearance carries far more information than the number does. Source: NCCN Ovarian Cancer guidelines; established CA-125 interpretation practice.
This gets reported in two unhelpful ways — either dismissed entirely or presented as alarming. Neither is accurate, so here is the actual position.
Endometriosis is associated with an increased risk of two specific ovarian cancer subtypes — clear-cell and endometrioid. The association is consistent across studies and is thought to reflect a genuine biological pathway, in which repeated bleeding and inflammation within the cyst can, rarely, lead to malignant change. Risk appears higher with long-standing endometriomas, with larger ones, and with increasing age, particularly after 45.
The absolute risk stays low. The overwhelming majority of women with endometriomas never develop ovarian cancer, and endometriosis is common while these cancer subtypes are not. An endometrioma is not a pre-cancerous lesion in the way that, for example, atypical endometrial hyperplasia is. The practical consequence is monitoring and treatment of the endometriosis — not surveillance for cancer, and certainly not preventive surgery on risk grounds alone.
For most women the cancer question is answered in a sentence and the real subject is everything else — pain, fertility, and whether the cyst needs removing.
An endometrioma is rarely an isolated finding. It usually indicates endometriosis elsewhere in the pelvis — on the peritoneum, the uterosacral ligaments, the bowel or the bladder — much of which does not show on ultrasound at all. An MRI of the pelvis characterises deep endometriosis far better and is worth doing where symptoms suggest more extensive disease.
This matters because endometriosis is frequently diagnosed many years after symptoms begin, often after women have been told repeatedly that severe period pain is normal. Naming the condition is what unlocks effective treatment, and the delay is the single most common failure in this area.
Endometriosis is oestrogen-driven, so treatments that suppress ovulation and reduce cyclical hormonal fluctuation reduce pain and can limit further growth. Combined hormonal contraception, progestogen-only options including the hormonal coil, and other suppressive treatments are all used, chosen according to symptoms, fertility plans and tolerance.
Hormonal treatment controls symptoms well for many women but does not make an existing endometrioma disappear. It is a management strategy rather than a cure, and it works best alongside a clear plan for what happens if pain is not controlled.
Removal is considered where pain is not controlled by medical treatment, where the cyst is large, where it is growing, where fertility treatment is planned, or where the appearance changes in a way that needs a tissue diagnosis. Laparoscopic cystectomy removes the cyst wall while preserving the rest of the ovary.
There is a genuine trade-off to weigh. Removing an endometrioma can reduce ovarian reserve, because healthy ovarian tissue is inevitably lost alongside the cyst wall — which matters a great deal if you hope to conceive. This is a decision to make with a specialist who will discuss both sides rather than default to operating.
Endometriosis is associated with reduced fertility through several mechanisms, including distorted pelvic anatomy, inflammation and reduced ovarian reserve. Many women with endometriomas conceive without difficulty; others need assistance. The presence of an endometrioma alone does not determine the outcome.
If you are planning a pregnancy, this is worth raising early rather than after difficulty arises, because it affects the surgical decision above. Assessment of ovarian reserve and a discussion about the sequence of treatment and conception attempts is time well spent. See fertility and ovarian health.
An endometrioma being managed without surgery is monitored with periodic ultrasound, checking size and — more importantly — appearance. The point of monitoring is not routine cancer screening; it is to detect the uncommon change that would alter management.
The changes that matter are the development of solid areas or nodules within the cyst, the appearance of internal blood flow on Doppler where there was none, rapid growth, and any change in the character of the pain. Any of these prompts prompt reassessment rather than waiting for the next scheduled scan.
Endometriosis is oestrogen-driven, so it typically becomes quiescent after the menopause and endometriomas often shrink or resolve. That is the expected course, and it is reassuring.
An endometrioma that persists, grows or changes appearance after the menopause behaves against expectation, and it is assessed more carefully for that reason. This is one of the specific situations where the modest cancer association becomes clinically relevant rather than theoretical. See ovarian cysts after menopause.
None of these means cancer. Each is a change from expected behaviour and is worth reporting rather than waiting for the next scheduled scan.
A previously uniform ground-glass cyst developing solid components or nodules is the change that matters most on a follow-up scan.
Colour Doppler flow appearing within the cyst where there was none before warrants reassessment rather than routine watching.
An endometrioma that enlarges substantially between scans is behaving differently and should prompt further characterisation.
Endometriosis usually becomes quiescent after the menopause. A cyst that does not follow that course is assessed more carefully.
Pain that becomes constant when it was cyclical, or that is joined by persistent bloating or early satiety, is worth reporting.
Monitoring an endometrioma is not cancer surveillance. It is watching for the uncommon change in behaviour that would alter what is done next.
Most women with an endometrioma have lived with severe pain for years before anyone named it. A proper assessment changes both the pain and the monitoring plan.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. The cancer risk is modest and often overstated — the pain is real and worth treating.
Two things usually bring women to a page like this. One is a raised CA-125 that nobody put in context. The other is having read that endometriosis increases ovarian cancer risk, without the sentence that follows about how small the absolute risk is. Both are resolvable in a single conversation, and both cause a great deal of unnecessary fear in the meantime.
Your first consultation at CION is free and runs to about 45 minutes. We will put the CA-125 in context, explain what the scan appearance means, and be specific about what the monitoring is actually looking for. Where the more useful subject turns out to be your pain or your fertility rather than cancer risk — which is usually the case — we will say so and direct you accordingly.
Where a cyst does change in a way that needs specialist care, CION delivers medical oncology in-house: chemotherapy and maintenance therapy across 35+ centres in Telangana and Andhra Pradesh, alongside genetic counselling where family history or a diagnosis warrants it. Ovarian surgery, including cystectomy and any debulking procedure, is coordinated with specialist gynaecology and gynaecologic-oncology partner centres and may be billed there.
Free and unhurried. Long enough to cover the cancer question and then get to the subjects that usually matter more.
A raised result alongside a classic endometrioma in a premenopausal woman is expected. We say so rather than escalating.
Removing an endometrioma costs ovarian reserve. That trade-off is discussed properly rather than defaulting to an operation.
Monitoring scans and any subsequent care near where you live across Telangana and Andhra Pradesh.
A quick comparison with the other cyst types most often confused with it on a scan report.
| Cyst type | Ultrasound appearance | Natural history |
|---|---|---|
| Endometrioma | Uniform ground-glass echoes, no solid areas, no internal flow. | Persists; usually shrinks after menopause. Benign, modest subtype-specific cancer link. |
| Haemorrhagic cyst | Lacy, reticular or fishnet strands of fibrin. | Resolves within about 6-12 weeks. Benign, no cancer link. |
| Dermoid | Bright echogenic areas with shadowing, fat-fluid level. | Persists and slowly grows. Benign; malignant change rare. |
| Simple cyst | Completely clear fluid, thin wall, one compartment. | Often resolves if functional. Very low malignancy risk at any age. |
| Cystadenoma | Thin septations, clear or thicker fluid, no solid areas. | Persists and grows slowly. Benign; removed if sizeable. |
| Concerning mass | Solid components, papillary projections, internal Doppler flow. | Needs characterisation. Moves to specialist assessment. |
*An endometrioma and a haemorrhagic cyst can look similar on a single scan. The difference usually becomes obvious on a repeat scan — the haemorrhagic cyst has gone, the endometrioma has not.
No. An endometrioma is a benign cyst formed when endometriosis involves the ovary and fills with old altered blood. It has a characteristic and recognisable appearance on ultrasound — uniform ground-glass internal echoes with no solid areas and no internal blood flow. It will always be reported as a complex cyst, because it does not contain clear fluid, but that particular complex pattern is a known benign one. Endometriomas are associated with a modest increase in the risk of two specific ovarian cancer subtypes, but the absolute risk stays low and the great majority never undergo any malignant change.
Because endometriosis raises CA-125 routinely, and endometriomas raise it more than most other benign causes. CA-125 is a protein that rises in a long list of conditions involving inflammation of the peritoneal surfaces — endometriosis, fibroids, pelvic inflammatory disease, liver disease, and even a normal period. A raised result alongside a classic ground-glass cyst in a premenopausal woman is an expected finding rather than a warning sign. The scan appearance carries far more information than the number does, and this is precisely why CA-125 should never be read in isolation.
The association is real but modest, and it applies to two specific subtypes — clear-cell and endometrioid ovarian cancer — rather than to ovarian cancer generally. The absolute risk remains low: endometriosis is common and these subtypes are not, and the overwhelming majority of women with endometriomas never develop ovarian cancer. Risk appears somewhat higher with long-standing endometriomas, larger ones, and increasing age, particularly beyond 45. The practical implication is monitoring and proper treatment of the endometriosis, not cancer surveillance and not preventive surgery on risk grounds alone.
It depends on your symptoms and your plans rather than on cancer risk. Removal is considered where pain is not controlled by medical treatment, where the cyst is large or growing, where fertility treatment is planned, or where the appearance changes in a way that needs a tissue diagnosis. There is a genuine trade-off: laparoscopic cystectomy removes the cyst wall but inevitably takes some healthy ovarian tissue with it, which can reduce ovarian reserve. That matters considerably if you hope to conceive, so it is a decision to make with a specialist who will weigh both sides.
Not while you are still having periods. Unlike functional and haemorrhagic cysts, which resolve within weeks to a few months, an endometrioma persists because it is being maintained by the underlying endometriosis. Hormonal treatment can control pain and limit further growth but does not usually make an existing endometrioma disappear. After the menopause the picture changes: endometriosis is oestrogen-driven, so it typically becomes quiescent and endometriomas often shrink or resolve. A cyst that persists, grows or changes appearance after the menopause is assessed more carefully.
The changes that matter are the development of solid areas or nodules within a cyst that was previously uniform, the appearance of internal blood flow on colour Doppler where there was none, rapid growth between scans, and persistence or growth after the menopause when the cyst would be expected to shrink. Alongside those, report any change in the character of your pain — particularly pain that becomes constant when it used to be cyclical — or the appearance of persistent bloating, feeling full quickly or new urinary urgency. Any of these warrants reassessment rather than waiting for the next scheduled scan.
The first consultation is free and runs to about 45 minutes. CION delivers medical oncology in-house, covering chemotherapy and maintenance treatment across more than 35 centres in Telangana and Andhra Pradesh, alongside genetic counselling where family history or a diagnosis warrants it. Ovarian surgery, including cystectomy and debulking, is coordinated with specialist partner centres and may be billed there — we state that upfront. For most women with an endometrioma the useful outcome is putting the CA-125 and the risk figures in context, and then discussing the pain and fertility questions that usually matter more.